The use of immunohistochemistry in the differential diagnosis of common epithelial tumours of the skin

Current Diagnostic Pathology

Volumn 13, Issue 4, 2007, Pages 237-251

  Sanders, D S A ^a   Carr, R A ^a  

^a Department of Pathology ^*  (United Kingdom)

Author keywords

BCC; BerEP4; CD10; Cytokeratin; EMA; Immunohistochemistry; Merkel cells; SCC; Skin tumours

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; CD34 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BEREP4; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CLEAR CELL CARCINOMA; CLINICAL PRACTICE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EPITHELIUM TUMOR; FIBROXANTHOMA; HIDRADENOMA; HUMAN; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LEIOMYOSARCOMA; MELANOMA; MERKEL CELL TUMOR; METASTASIS; NEUROENDOCRINE TUMOR; SEBACEOMA; SKIN TUMOR; SPINDLE CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; TRICHOBLASTOMA;

EID: 34548025324     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cdip.2007.05.012     Document Type: Article

References (73)

1. Latza U., Niedobitek G., Schwarting R., et al. Ber-EP4: a new monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 43 (1990) 213-219
2. Ozawa M., Aiba S., Kurosawa M., and Tagami H. Ber-EP4 antigen is a marker for a cell population related to the secondary hair germ. Exp Dermatol 13 (2004) 401-405
3. Jimenez F.J., Burchette Jr. J.L., Grichnik J.M., and Hitchcock M.G. Ber-EP4 immunoreactivity in normal skin and cutaneous neoplasms. Mod Pathol 8 (1995) 854-858
4. Tallachea O., Reis J.P., Domingues J.C., and Baptista A.P. Ber-EP4 distinguishes basal-cell from squamous cell carcinoma of the skin. Am J Dermatopathol 15 (1993) 452-455
5. Jones M.S., Helm K.F., and Maloney M.E. The immunohistochemical characteristics of the basosquamous cell carcinoma. Dermatol Surg 23 (1997) 181-184
6. Swanson P.E., Fitzpatrick M.M., Ritter J.H., et al. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens. J Cutan Pathol 25 (1998) 153-159
7. Tope W.D., Nowfar-Rad M., and Kist D.A. Ber-EP4-positive phenotype differentiates actinic keratosis from superficial basal cell carcinoma. Dermatol Surg 26 (2000) 415-418
8. Beer T.W., Shepherd P., and Theaker J.M. BerEP4 and epithelial membrane antigen and distinction of basal cell, squamous cell and basosquamous carcinomas of the skin. Histopathology 37 (2000) 218-223
9. Taibjee S.M., Sommerlad M.P., Sanders D.S.A., and Carr R.A. BerEP4 and EMA staining in basaloid and squamous skin tumours: the potential pitfall of positive BerEP4 staining in basaloid Bowen's. Br J Dermatol 155 Suppl. 1 (2006) 80
10. Fan Y.S., Carr R.A., Sanders D.S.A., Smith A.P., Lazar A.J.F., and Calonje E. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma. Histopathology 51 (2007) 80-86
11. Skelton H.G., Smith K.J., Hitchcock C.L., McCarthy W.F., Lupton G.P., and Graham J.H. Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol 37 (1997) 734-739
12. Pinkus G.S., and Kurtin P.J. Epithelial membrane antigen-a diagnostic discriminant in surgical pathology; immunohistochemical profile in epithelial, mesenchymal, and haemopoietic neoplasms using paraffin sections and monoclonal antibodies. Hum Pathol 16 (1985) 929-940
13. Demikeresen C., Hoede N., and Moll R. Epithelial markers and differentiation in adenexal neoplasms of the skin: an immunohistochemical study including individual cytokeratins. Am J Dermatopathol 18 (1996) 592-596
14. Sezaki N., Ishimaru F., Tabayashi T., et al. The type 1 CD10/neutral endopeptidase 24.11 promoter: functional characterization of the 5′-untranslated region. Br J Haematol 12 (2003) 177-183
15. Ordi J., Romagosa C., Tavassoli F.A., et al. CD10 expression in epithelial tissues and tumors of the gynecologic tract: a useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors. Am J Surg Pathol 27 (2003) 178-186
16. Perna A.G., Smith M.J., Krishnan B., and Reed J.A. CD10 is expressed in cutaneous clear cell lesions of different histogenesis. J Cutan Pathol 32 (2005) 348-351
17. Bahrami S., Malone J.C., Lear S., and Martin A.W. CD10 expression in cutaneous adnexal neoplasms and a potential role for differentiating cutaneous metastatic renal cell carcinoma. Arch Pathol Lab Med 130 (2006) 1315-1319
18. Kanitakis J., Bourchany D., and Claudy A. Expression of the CD10 antigen (neural endopeptidase) by mesenchymal tumours of the skin. Anticancer Res 20 (2000) 3539-3544
19. Pham T.T.N., Selim M.A., Burchette Jr. J.L., Madden J., Turner J., and Herman C. CD10 expression in trichoepithelioma and basal cell carcinoma. J Cutan Pathol 33 (2006) 123-128
20. Mirza B., and Weedon D. Atypical fibroxanthoma; a clinicopathological study of 89 cases. Australas J Dermatol 46 (2005) 235-238
21. Nicholoff B.J. The human progenitor cell antigen (CD34) is localised on endothelial cells, dermal dendritic cells and perifollicular cells in formalin fixed normal skin, and proliferating endothelial cells and stromal spindle cells in Kaposi's sarcoma. Arch Dermatopathol 127 (1991) 523-529
22. Poblet E., Jiminez-Acosta F., and Rocamora A. QBEND/10 (anti-CD34 antibody) in external root sheath cells and follicular tumours. J Cutan Pathol 21 (1994) 224-228
23. Poblet E., Jiminez F., Godinez J.M., Pascual-Martin A., and Izeta A. The immunohistochemical expression of CD34 in human hair follicles: a comparative study with the bulge marker CK15. Clin Exp Dermatol 31 (2006) 807-812
24. Kirchmann T.T., Prieto V.G., and Smoller B.R. CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma. Arch Dermatol 130 (1994) 589-592
25. Kirchmann T.T.T., Prieto V.G., and Smoller B.R. Use of CD34 in assessing the relationship between stroma and tumour in desmoplastic keratinocytic neoplasms. J Cutan Pathol 22 (1995) 422-426
26. Bryant D., and Penneys N.S. Immunostaining for CD34 to determine trichoepithelioma. Arch Dermatol 131 (1995) 616-617
27. Verhaegh M.E., Arends J.W., Majoie I.M., Hoekzema R., and Neumann H.A. Transforming growth factor-beta and bcl-2 distribution patterns distinguish trichoepithelioma from basal cell carcinoma. Dermatol Surg 23 (1997) 695-700
28. Schirren C.G., Rutten A., Kaudewitz P., Diaz C., McClain S., and Burgdorf W.H. Trichoblastoma and basal cell carcinoma are neoplasms with follicular differentiation sharing the same profile of cytokeratin intermediate filaments. Am J Dermatopathol 19 (1997) 341-350
29. Basarab T., Orchard G., and Russell-Jones R. The use of immunostaining for bcl-2 and CD34 and the lectin peanut agglutinin in differentiating between basal cell carcinomas and trichoepitheliomas. Am J Dermatopathol 20 (1998) 448-452
30. McNiff J.M., Eisen R.N., and Glusac E.J. Immunohistochemical comparison of cutaneous lymphadenoma, trichoblastoma, and basal cell carcinoma: support for classification of lymphadenoma as a variant of trichoblastoma. J Cutan Pathol 26 (1999) 119-124
31. Poniecka A.W., and Alexis J.B. An immunohistochemical study of basal cell carcinoma and trichoepithelioma. Am J Dermatopathol 21 (1999) 332-336
32. Gold P., and Freedman S.O. Demonstration of tumour-specific antigens in human colonic carcinomata by immunological tolerance and absorbsion techniques. J Exp Med 121 (1965) 439-462
33. Thompson J., and Zimmerman W. The carcinoembryonic gene family; structure, expression and evolution. Tumour Biol 9 (1988) 63-68
34. Sanders D.S.A., Wilson C.A., Bryant F.J., et al. Classification and localisation of carcioembryonic (CEA) related antigen expression in normal oesophageal squamous mucosa and squamous carcinoma. Gut 35 (1994) 1022-1025
35. Demirkesen C., Hoede N., and Moll R. Epithelial markers and differentiation in adnexal neoplasms of the skin: an immunohistochemical study including individual cytokeratins. J Cutan Pathol 22 (1995) 518-535
36. Chu P.G., Wu E., and Weiss L.M. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 13 (2000) 962-972
37. Moll R., Moll I., and Franke W.W. Differences of expression of cytokeratin polypeptides in various epithelial skin tumors. Arch Dermatol Res 276 (1984) 349-363
38. Yamamoto O., and Asahi M. Cytokeratin expression in trichoblastic fibroma (small nodular type trichoblastoma), trichoepithelioma and basal cell carcinoma. Br J Dermatol 140 (1999) 8-16
39. Jih D.M., Lyle S., Elenitsas R., Elder D.E., and Cotsarelis G. Cytokeratin 15 expression in trichoepitheliomas and a subset of basal cell carcinomas suggests they originate from hair follicle stem cells. J Cutan Pathol 26 (1999) 113-118
40. Habets J.M., Tank B., Vuzevski V.D., Breve J., Stolz E., and van Joost T. Absence of cytokeratin 8 and inconsistent expression of cytokeratins 7 and 19 in human basal cell carcinoma. Anticancer Res 8 (1988) 611-616
41. Markey A.C., Lane E.B., Macdonald D.M., and Leigh I.M. Keratin expression in basal cell carcinomas. Br J Dermatol 126 (1992) 154-160
42. Kurzen H., Esposito L., Langbein L., and Hartschuh W. Cytokeratins as markers of follicular differentiation: an immunohistochemical study of trichoblastoma and basal cell carcinoma. Am J Dermatopathol 23 (2001) 501-509
43. Wang N.P., Zee S., Zarbo R.J., Bacchi C.E., and Gown A.M. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 3 (1995) 99-107
44. Qureshi H.S., Ormsby A.H., Lee M.W., Zarbo R.J., and Ma C.K. The diagnostic utility of p63, CK5/6, CK 7, and CK 20 in distinguishing primary cutaneous adnexal neoplasms from metastatic carcinomas. J Cutan Pathol 31 (2004) 145-152
45. Ohnishi T., and Watanabe S. Immunohistochemical analysis of cytokeratin expression in various trichogenic tumors. Am J Dermatopathol 21 (1999) 337-343
46. Aslan F., Demirkesen C., Cagatay P., and Tuzuner N. Expression of cytokeratin subtypes in intraepidermal malignancies: a guide for differentiation. J Cutan Pathol 33 (2006) 531-538
47. Mahmoodi M., Asad H., Salim S., Kantor G., and Minimo C. Anti-cytokeratin 20 staining of Merkel cells helps differentiate basaloid proliferations overlying dermatofibromas from basal cell carcinoma. J Cutan Pathol 32 (2005) 491-495
48. Schulz T., and Hartschuh W. Merkel cells are absent in basal cell carcinomas but frequently found in trichoblastomas: an immunohistochemical study. J Cutan Pathol 24 (1997) 14-24
49. Hartschuh W., and Schulz T. Merkel cells are integral constituents of desmoplastic trichoepithelioma: an immunohistochemical and electron microscopic study. J Cutan Pathol 22 (1995) 413-421
50. Sigel J.E., Skacel M., Bergfeld W.F., House N.S., Rabkin M.S., and Goldblum J.R. The utility of cytokeratin 5/6 in the recognition of cutaneous spindle cell squamous cell carcinoma. J Cutan Pathol 28 (2001) 520-524
51. Plumb S.J., Argenyi Z.B., Stone M.S., and De Young B.R. Cytokeratin 5/6 immunostaining in cutaneous adnexal neoplasms and metastatic adenocarcinoma. Am J Dermatopathol 26 (2004) 447-451
52. Klymkowski M.W. β Catenin and its regulatory network. Hum Pathol 36 (2005) 225-227
53. Moreno-Bueno G., Gamallo C., Perez-Gallego L., Contreras F., and Palacios J. β Catenin expression in pilomatrixomas: relationship with β Catenin gene mutations and comparison with β Catenin expression in normal hair follicles. Br J Dermatol 145 (2001) 576-581
54. Lazar A.J., Calonje E., Grayson W., et al. Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding β Catenin. J Cutan Pathol 32 (2005) 148-157
55. Hassanein A.M., and Glanz S.M. β Catenin expression in benign and malignant pilomatrix neoplasms. Br J Dermatol 150 (2004) 511-516
56. Haskell H.D., Haynes H.A., McKee P.H., et al. Basal cell carcinoma with matrical differentiation: a case study with analysis of β Catenin. J Cutan Pathol 32 (2005) 245-250
57. Cerroni L., and Kerl H. Aberrant bcl-2 protein expression provides a possible mechanism of neoplastic cell growth in cutaneous basal cell carcinoma. J Cutan Pathol 21 (1994) 398-403
58. Crowson A.N., Magro C.M., Kadin M.E., and Stranc M. Differential expression of bcl-2 oncogene in human basal cell carcinoma. Hum Pathol 27 (1996) 355-359
59. Smoller B.R., Van De Rijn M., Lebrun D., and Warnke R.A. Bcl-2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas. Br J Dermatol 131 (1994) 28-31
60. Mills A.E. Solar keratosis can be distinguished from superficial basal cell carcinoma by expression of Bcl-2. Am J Dermatopathol 19 (1997) 443-445
61. Campbell C., Quinn A.G., Angus B., and Rees J.L. The relation between p53 mutation and p53 immunostaining in non-melanoma skin cancer. Br J Dermatol 129 (1993) 235-241
62. Shea C.R., McNutt N., Volkenandt M., Lugo J., Prioleau P.G., and Albino A.P. Overexpression of p53 protein in basal cell carcinomas of human skin. Am J Pathol 141 (1992) 25-29
63. McGregor J.M., Yu C.C., Dublin E.A., Levison D.A., and MacDonald D.M. Aberrant expression of p53 tumour-suppressor protein in non-melanoma skin cancer. Br J Dermatol 127 (1992) 463-469
64. Haerslev T., Rossen K., Hou-Jensen K., and Jacobsen G.K. Immunohistochemical detection of p53 in epidermal proliferations overlying dermatofibromas. Acta Derm Venereol 75 (1995) 187-189
65. Taner A., Sait S., Ayla Y., and Gulsen K. p53 expression in eccrine poroma and porocarcinoma. Am J Dermatopathol 23 (2001) 402-406
66. Abdelsayed R.A., Guijarro-Rojas M., Ibrahim N.A., and Sangueza O.P. Immunohistochemical evaluation of basal cell carcinoma and trichoepithelioma using Bcl-2, Ki-67, PCNA, and p53. J Cutan Pathol 27 (2000) 169-175
67. Ko C.J., Cochran A.J., Eng W., and Binder S.W. Hidradenocarcinoma: a histological and immunohistochemical study. J Cutan Pathol 33 (2006) 726-730
68. Lantuejoul S., Moro D., Michalides R.J., et al. Neural cell adhesion molecule (NCAM) and NCAM-PSA expression in neuroendocrine lung tumours. Am J Surg Pathol 22 (1998) 1267-1276
69. Ivan D., Diwan A.H., and Prieto V.G. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to skin. Mod Pathol 18 (2005) 137-142
70. Emanuel P., Wang B., Wu M., and Burstein D.E. p63 immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous carcinoma. Mod Pathol 18 (2005) 645-650
71. Kaufmann O., Fietze E., Mengs J., and Dietel M. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Anat Pathol 116 (2001) 823-830
72. Thewes M., Worret W.I., and Engst R. Ring stromelysin-3: a potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma. J Am J Dermatopathol 20 (1998) 140-142
73. Kruse R., Rutten A., Schweiger N., et al. Frequency of microsatellite instability in unselected sebaceous tumours. J Invest Dermatol 120 (2003) 858-864